| Name | Kidd Drug And Gift |
|---|---|
| Organization Name | Kidd Healthmart Drug Co |
| Location | 104 N Main St, Fairview, Oklahoma 73737 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (580) 227-4685 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Children born to women who had gestational diabetes and drank at least one artificially sweetened beverage per day during pregnancy were more likely to be overweight or obese at age 7, compared to children born to women who had gestational diabetes and drank water instead of artificially sweetened beverages, according to a study led by researchers at the National Institutes of Health.
Celsion Corporation (NASDAQ:CLSN) announced today the Data Safety Monitoring Board ("DSMB") has reviewed the safety data from the first group of patients enrolled in its pivotal ThermoDox® Phase III clinical trial for primary liver cancer ("HEAT study") and has recommended that Celsion continue to enroll patients in the trial.
Some of the issues to be addressed at the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York "are controversial, including those relating to intellectual property rights for new medicines, diagnostics and medical devices," James Love, director of Knowledge Ecology International, writes in an Al Jazeera opinion piece.
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
› Verified 4 days ago
| NPI Number | 1295880185 |
| Organization Name | KIDD HEALTHMART DRUG CO |
| Doing Business As | KIDD DRUGS GIFT INC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 104 N Main St, Fairview, OK 73737 |
| Phone Number | 580-227-4685 |
News Archive
Children born to women who had gestational diabetes and drank at least one artificially sweetened beverage per day during pregnancy were more likely to be overweight or obese at age 7, compared to children born to women who had gestational diabetes and drank water instead of artificially sweetened beverages, according to a study led by researchers at the National Institutes of Health.
Celsion Corporation (NASDAQ:CLSN) announced today the Data Safety Monitoring Board ("DSMB") has reviewed the safety data from the first group of patients enrolled in its pivotal ThermoDox® Phase III clinical trial for primary liver cancer ("HEAT study") and has recommended that Celsion continue to enroll patients in the trial.
Some of the issues to be addressed at the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York "are controversial, including those relating to intellectual property rights for new medicines, diagnostics and medical devices," James Love, director of Knowledge Ecology International, writes in an Al Jazeera opinion piece.
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
› Verified 4 days ago
News Archive
Children born to women who had gestational diabetes and drank at least one artificially sweetened beverage per day during pregnancy were more likely to be overweight or obese at age 7, compared to children born to women who had gestational diabetes and drank water instead of artificially sweetened beverages, according to a study led by researchers at the National Institutes of Health.
Celsion Corporation (NASDAQ:CLSN) announced today the Data Safety Monitoring Board ("DSMB") has reviewed the safety data from the first group of patients enrolled in its pivotal ThermoDox® Phase III clinical trial for primary liver cancer ("HEAT study") and has recommended that Celsion continue to enroll patients in the trial.
Some of the issues to be addressed at the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York "are controversial, including those relating to intellectual property rights for new medicines, diagnostics and medical devices," James Love, director of Knowledge Ecology International, writes in an Al Jazeera opinion piece.
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
› Verified 4 days ago
Kidd Drug And Gift Type: Durable Medical Equipment & Medical Supplies Supplier Location: 104 N Main St, Fairview, Oklahoma 73737 Phone: (580) 227-4685 | |
Fairview Rx Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 210 E State Rd, Fairview, Oklahoma 73737 Phone: (580) 227-2045 | |
Max Carlisle Od Pc Type: Medicare Supplier Location: 111 E Broadway, Fairview, Oklahoma 73737 Phone: (580) 227-4878 |